What do Mass General, the NCI and Mayo Clinic have in common? They routinely blow off an FDA rule on posting trial results
Two years ago, an FDA rule went into effect requiring all clinical trials to report their results on clinicaltrials.gov within a year of completion. It was meant to guard against a publication bias that can leave negative results unpublished and skew the literature and, by extension, our understanding of how and if drugs work.
A team at Ben Goldacre’s Evidence-Based Medicines Data Lab at the University of Oxford just examined how well trial organizers are complying with those rules, and the results, at least for some organizations, are damning.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 70,500+ biopharma pros reading Endpoints daily — and it's free.